Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2026)

Hims & Hers Health's (HIMS) quarterly Change in Accured Expenses came in at $10.0 million in Q1 2026, up 130.2% year-on-year from $4.4 million in Q1 2025, and up 625.22% quarter-over-quarter from -$1.9 million in Q4 2025.

Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Change in Accured Expenses across 8 years of filings, most recently posting $10.0 million for Q1 2026.

  • Change in Accured Expenses for Q1 2026 came in at $10.0 million, up 130.2% year-over-year; the trailing twelve-month figure through Mar 2026 was -$37.4 million (down 222.99% YoY), and the FY2025 annual result was -$43.1 million, down 280.96% from the prior year.
  • Change in Accured Expenses came in at $10.0 million for Q1 2026 at Hims & Hers Health, up from -$1.9 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $14.0 million in Q3 2024 to a low of -$52.9 million in Q3 2025.
  • The 5-year median for Change in Accured Expenses is $3.3 million (2022), against an average of $481588.2.
  • Across the five-year window, Change in Accured Expenses plunged 565.29% in 2022 and soared 507.26% in 2024, its largest moves.
  • Hims & Hers Health's Change in Accured Expenses stood at -$4.6 million in 2022, then soared by 134.96% to $1.6 million in 2023, then jumped by 507.26% to $9.8 million in 2024, then sank by 119.48% to -$1.9 million in 2025, then soared by 625.22% to $10.0 million in 2026.
  • The last three Change in Accured Expenses figures came in at $10.0 million (Q1 2026), -$1.9 million (Q4 2025), and -$52.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -144.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -234.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -12.70 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -14.30 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 4.89 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 23.00 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 10.02 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 14.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.02 Mn
Mar 31, 2026 10.02 Mn
Dec 31, 2025 -1.91 Mn
Dec 31, 2025 -1.91 Mn
Sep 30, 2025 -52.88 Mn
Sep 30, 2025 -52.88 Mn
Jun 30, 2025 7.39 Mn
Jun 30, 2025 7.39 Mn
Mar 31, 2025 4.35 Mn
Mar 31, 2025 4.35 Mn
Dec 31, 2024 9.79 Mn
Dec 31, 2024 9.79 Mn
Sep 30, 2024 14.03 Mn
Sep 30, 2024 14.03 Mn
Jun 30, 2024 2.23 Mn
Jun 30, 2024 2.23 Mn
Mar 31, 2024 -2.26 Mn
Mar 31, 2024 -2.26 Mn
Dec 31, 2023 1.61 Mn
Dec 31, 2023 1.61 Mn